Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{AA}} | {{CMG}} {{AE}}{{AA}} | ||
==Overview== | ==Overview== | ||
Intravenous [[beta blockers]], [[diltiazem]], [[procainamide]], or [[verapamil]] is reasonable for acute treatment in patients with symptomatic [[junctional tachycardia]]. Oral beta blockers, diltiazem or verapamil is reasonable for ongoing management in patients with junctional tachycardia. [[Flecainide]] or [[propafenone]] may be reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have junctional tachycardia. [[Catheter ablation]] may be reasonable in patients with junctional tachycardia when medical therapy is not effective or contraindicated.<ref name="pmid26409259">{{cite journal| author=Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al.| title=2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2016 | volume= 67 | issue= 13 | pages= e27-e115 | pmid=26409259 | doi=10.1016/j.jacc.2015.08.856 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26409259 }} </ref> | |||
== Management of Junctional Tachycardia== | == Management of Junctional Tachycardia== | ||
2015 AHA recommendations for the management of [[junctional tachycardia]] are described below:<ref name="pmid26409259">{{cite journal| author=Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al.| title=2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2016 | volume= 67 | issue= 13 | pages= e27-e115 | pmid=26409259 | doi=10.1016/j.jacc.2015.08.856 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26409259 }} </ref> | 2015 AHA recommendations for the management of [[junctional tachycardia]] are described below:<ref name="pmid26409259">{{cite journal| author=Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al.| title=2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2016 | volume= 67 | issue= 13 | pages= e27-e115 | pmid=26409259 | doi=10.1016/j.jacc.2015.08.856 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26409259 }} </ref> |
Latest revision as of 16:47, 27 October 2016
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
FDA on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
CDC on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
Blogs on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Intravenous beta blockers, diltiazem, procainamide, or verapamil is reasonable for acute treatment in patients with symptomatic junctional tachycardia. Oral beta blockers, diltiazem or verapamil is reasonable for ongoing management in patients with junctional tachycardia. Flecainide or propafenone may be reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have junctional tachycardia. Catheter ablation may be reasonable in patients with junctional tachycardia when medical therapy is not effective or contraindicated.[1]
Management of Junctional Tachycardia
2015 AHA recommendations for the management of junctional tachycardia are described below:[1]
Acute Treatment of Junctional Tachycardia
Class IIa |
"1. Intravenous beta blockers are reasonable for acute treatment in patients with symptomatic junctional tachycardia "(Level of Evidence:C-LD ) " |
"2. Intravenous diltiazem, procainamide, or verapamil is reasonable for acute treatment in patients with junctional tachycardia "(Level of Evidence:C-LD ) " |
Management of ongoing Junctional Tachycardia
Class IIa |
"1. Oral beta blockers are reasonable for ongoing management in patients with junctional tachycardia "(Level of Evidence:C-LD) " |
"2. Oral diltiazem or verapamil is reasonable for ongoing management in patients with junctional tachycardia "(Level of Evidence:C-LD) " |
Class IIb |
"1. Flecainide or propafenone may be reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have junctional tachycardia "(Level of Evidence:C-LD) " |
"2. Catheter ablation may be reasonable in patients with junctional tachycardia when medical therapy is not effective or contraindicated "(Level of Evidence:C-LD) " |
References
- ↑ 1.0 1.1 Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.